logo

For the Inventor, By the Inventor

The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Patent No.:

US 10729673 B1

PDFFull Text
Date of Patent:
Aug. 04, 2020

Filed:

Jan. 30, 2020

Taxane particles and their use

Applicant:

Crititech, Inc., Lawrence, KS (US);

Inventors:

Michael Baltezor, Lawrence, KS (US);

Joseph Farthing, Lawrence, KS (US);

Jake Sittenauer, Lawrence, KS (US);

Jahna Espinosa, Lawrence, KS (US);

Samuel Campbell, Lawrence, KS (US);

Matthew McClorey, Lawrence, KS (US);

Julia K. Fischer, Lawrence, KS (US);

Mark D. Williams, Lawrence, KS (US);

Gary E. Clapp, Lawrence, KS (US);

Assignee:

Crititech, Inc., Lawrence, KS (US);

Attorney:

McDonnell Boehnen Hulbert & Berghoff LLP

Primary Examiner:

Aradhana Sasan

Int. Cl.
CPC ...
A61K 31/337 (2006.01); A61K 9/00 (2006.01); A61K 9/10 (2006.01); A61K 9/14 (2006.01); A61K 9/16 (2006.01); A61K 9/51 (2006.01); A61J 3/02 (2006.01); B01J 19/10 (2006.01); B01J 19/26 (2006.01); B01J 2/04 (2006.01); B01J 3/00 (2006.01); B01J 4/00 (2006.01); B01D 46/24 (2006.01); B01J 3/02 (2006.01); B05B 1/34 (2006.01); B05B 13/02 (2006.01);
U.S. Cl.
CPC ...
A61K 31/337 (2013.01); A61J 3/02 (2013.01); A61K 9/0019 (2013.01); A61K 9/10 (2013.01); A61K 9/14 (2013.01); A61K 9/1605 (2013.01); A61K 9/1682 (2013.01); A61K 9/1688 (2013.01); A61K 9/5192 (2013.01); B01D 46/24 (2013.01); B01J 2/04 (2013.01); B01J 3/008 (2013.01); B01J 3/02 (2013.01); B01J 4/002 (2013.01); B01J 19/10 (2013.01); B01J 19/26 (2013.01); B05B 1/3489 (2013.01); B05B 13/0278 (2013.01); B01D 2271/02 (2013.01); B05D 2401/90 (2013.01);
Abstract

Compositions are provided that include having at least 95% by weight of a taxane, or a pharmaceutically acceptable salt thereof, where the particles have a mean bulk density between about 0.050 g/cmand about 0.15 g/cm, and/or a specific surface area (SSA) of at least 18 m/g, 20 m/g, 25 m/g, 30 m/g, 32 m/g, 34 m/g, or 35 m/g. Methods for making and using such compositions are also provided.

Find Patent Forward Citations

Loading…